ロード中...
Curing Ph(+) ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant
The understanding and treatment of Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia have changed rapidly in the past 10 years. The outcome is equally as good as for Ph(−) disease, and with targeted tyrosine kinase inhibitor therapies in addition to chemotherapy, the novel immuno...
保存先:
| 出版年: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913432/ https://ncbi.nlm.nih.gov/pubmed/31808885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|